✦ LIBER ✦

Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV)

✍ Scribed by Beaulieu, Pierre L.; Bös, Michael; Cordingley, Michael G.; Chabot, Catherine; Fazal, Gulrez; Garneau, Michel; Gillard, James R.; Jolicoeur, Eric; LaPlante, Steven; McKercher, Ginette; Poirier, Martin; Poupart, Marc-André; Tsantrizos, Youla S.; Duan, Jianmin; Kukolj, George

Book ID: 127253914
Publisher: American Chemical Society
Year: 2014
Tongue: English
Weight: 105 KB
Volume: 57
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm501225c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in the NS5A gene of hepatitis

Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b

✍ Hofgärtner, Wolfgang T.; Polyak, Stephen J.; Sullivan, Daniel G.; Carithers, Rob 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 3 views

Previous studies from Japan have described an association between a conserved sequence within the hepatitis C virus (HCV) genome and resistance to interferon (IFN) therapy for patients infected with HCV genotype 1b [

Characterization of vaniprevir, a hepati

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB

876 ACH-3102, A SECOND GENERATION NS5A I

876 ACH-3102, A SECOND GENERATION NS5A INHIBITOR, DEMONSTRATES POTENT ANTIVIRAL ACTIVITY IN PATIENTS WITH GENOTYPE 1a HCV INFECTION DESPITE THE PRESENCE OF BASELINE NS5A-RESISTANT VARIANTS

✍ Muir, A.; Hill, J.; Lawitz, E.; Marbury, T.; Robarge, L.; Robison, H.; Hui, J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

1163 A PHASE 2A STUDY OF BMS-791325, AN

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

✍ Tatum, H.; Thuluvath, P.; Lawitz, E.; Martorell, C.T.; Demicco, M.; Cohen, S.; R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Interferon-α 2b treatment of chronic act

Interferon-α 2b treatment of chronic active hepatitis C in patients co-infected with the human immunodeficiency virus (HIV): HCV viremia quantified by B-DNA and genotypic analysis 1111221. Dept. of Gastroenterology1 and Hematology2, Hospital Geral de Santo António, Oporto, Portugal

📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB